TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma.

Jason A Chesney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.